Gene-silencing strategy opens new path to understanding Down Syndrome
The first evidence that the underlying genetic defect responsible for trisomy 21, also known as Down syndrome, can be suppressed in laboratory cultures of patient-derived stem cells was presented today (Oct. 22) at the American ...
Oct 22, 2013
0
0